Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2009
10/22/2009US20090263411 Compositions, splice variants and methods relating to ovarian specific genes and proteins
10/22/2009US20090263406 JY-1 Regulation Of Granulosa Cell Function And Early Embryonic Development In Cattle
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263394 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
10/22/2009US20090263392 Methods of modifying antibodies for purification of bispecific antibodies
10/22/2009US20090263388 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
10/22/2009US20090263386 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
10/22/2009US20090263383 Antibodies to angiogenesis inhibiting domains of CD148
10/22/2009US20090263382 Stable and soluble antibodies inhibiting tnf alpha
10/22/2009US20090263380 Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
10/22/2009US20090263358 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy
10/22/2009US20090263351 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
10/22/2009US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing
10/22/2009US20090263318 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
10/22/2009US20090262219 Digital Camera
10/22/2009CA2758642A1 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
10/22/2009CA2721231A1 Sequence diversity generation in immunoglobulins
10/22/2009CA2721202A1 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
10/22/2009CA2721169A1 Prostate specific membrane antigen antibodies and antigen binding fragments
10/22/2009CA2721032A1 Anti-areg/hb-egf antibodies and treatment
10/22/2009CA2720210A1 Compositions comprising antibodies or antibody fragments
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP2110436A1 Polypeptides having neutrophil stimulating activity
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2110139A2 Method for identifying an anti-myelin associated glycoprotein (MAG) antibody
10/21/2009EP2110138A1 Dosages for treatment of anti-erbB2 antibodies
10/21/2009EP2110137A1 Vaccine against neisseria infection
10/21/2009EP2109625A2 Use of antibody conjugates
10/21/2009EP2109624A1 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor
10/21/2009EP2109623A2 Treatment of cancer with anti-il-1 antibodies
10/21/2009EP2109622A2 High affinity antibodies that neutralize staphylcoccus enterotoxin b
10/21/2009EP2109460A1 Anti-kir antibodies, formulations, and uses thereof
10/21/2009EP1716176B1 Cd38 splice variant and uses thereof
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009EP1499885B1 Novel fusion proteins and assays for molecular binding
10/21/2009EP1429623B1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
10/21/2009EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/21/2009EP1392359B1 Specific binding proteins and uses thereof
10/21/2009EP1292680B1 Agonist anti-trk-c monoclonal antibodies
10/21/2009EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/21/2009EP1047784B1 Neissera meningitidis antigens
10/21/2009EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009CN101563460A Selection method
10/21/2009CN101563454A Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma
10/21/2009CN101563366A Anti-NOTCH3 agonist antibodies and their use in the treatment of NOTCH3-related diseases
10/21/2009CN101563365A Anti-IL-6 monoclonal antibodies and uses thereof
10/21/2009CN101563362A Recombinant HCV E2 glycoprotein
10/21/2009CN101563104A Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
10/21/2009CN101563098A IL-17A/F heterologous polypeptides and therapeutic uses thereof
10/21/2009CN101563096A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
10/21/2009CN101560500A Cell strain LaDR5 for secreting tumor necrosis factor receptor induced antibody
10/21/2009CN101560257A Heavy metal copper monoclonal antibody and preparation method thereof
10/21/2009CN101560256A Method for preparing germs polyclonal antibody of sugarcane ratoon stunting disease
10/21/2009CN101560255A Anti-rabies virus monoclonal antibody and preparation method and application
10/21/2009CN100552027C Gene families associated with cancers
10/21/2009CN100551930C Peptides modulating caspase activation
10/20/2009US7605303 cloning a rice stress-responsive gene, RSI, using the isolated gene to breed NaCl and drought resistance plant but not resistance to abscisic acid; genetic engineering
10/20/2009US7605248 Recombinant constructs of Borrelia burgdorferi
10/20/2009US7605246 Genes differentially expressed in breast cancer
10/20/2009US7605238 Human CTLA-4 antibodies and their uses
10/20/2009US7605237 High affinity human antibodies to human IL-4 receptor
10/20/2009US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009US7605235 Immunoglobulins; Fc receptors; improved antibody-dependent cell mediated cytotoxicity (ADCC); cancer; transgenic animals; host cells
10/20/2009US7605234 Immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/20/2009US7605233 Tumour necrosis factor binding ligands
10/20/2009US7605229 Chimera; FC fragments; antibody overexpression; immunoglobulins; gene therapy
10/20/2009US7605142 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis
10/20/2009US7605133 Isolated peptides to treat alpha-synuclein diseases
10/20/2009US7605115 Subtilisin variants
10/20/2009US7605005 Method of screening for agents that modulate Tysnd1 level or activity in a cell.
10/20/2009US7604994 Genetically altered antibody-producing cell lines with improved antibody characteristics
10/20/2009US7604989 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
10/20/2009US7604958 Transfection, culturing; electrophoresis
10/20/2009US7604955 Detection of peptides which induce cytotoxic t-lymphocytes; provide imunoglobulin test peptide, incubate with cells, monitor mammalian cytotoxic T- lymphocyte response, isolate peptide which induce response
10/20/2009US7604947 Via biomarker, rex-1 gene, which controls stem cell differentiation; gene expression inhibition; RNA interference
10/20/2009US7604801 A substantially pure IgE anti-Parvovirus B19 antibody useful for diagnosis and prognosis of parvovirus infected patients by detecting the presence of immunoglobulin E anti-Parvovirus B19 antibodies; antibody-based compositions; viricides
10/20/2009US7604800 Antibodies and their derivatives that induce apoptosis upon binding to P-Selectin Glycoprotein Ligand-1 (PSGL-1) on activatedT cells; autoimmune diseases, transplant rejection, antiallergens, and T cell-derived cancers, anticarinogenic agents;immunosuppressants; induction of immunological tolerance
10/20/2009US7604799 Increasing phosphorylation; decreasing proliferation and/or metastatic behavior; cell lines, antibodies
10/20/2009CA2359667C Method of identifying n-terminal probnp
10/20/2009CA2330363C Diacylglycerol o-acyltransferase
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/15/2009WO2009126944A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009WO2009126898A2 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus( (jev) and their use
10/15/2009WO2009126858A2 Materials and methods for improved immunoglycoproteins
10/15/2009WO2009126725A1 Method of modulating neovascularization
10/15/2009WO2009126688A2 Novel compositions and methods for the treatment of immune related diseases
10/15/2009WO2009126659A1 Neutralization of gm-csf for the treatment of heart failure
10/15/2009WO2009126558A1 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (dnl) technology
10/15/2009WO2009126350A2 Methods and compositions for targeting polyubiquitin
10/15/2009WO2009125831A1 Monoclonal antibody directed against nk4
10/15/2009WO2009125825A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
10/15/2009WO2009125637A1 Method of discriminating bovine, thus discriminated bovine and kit for discriminating bovine
10/15/2009WO2009125395A1 Anti influenza antibodies and uses thereof
10/15/2009WO2009125394A1 Anti human immunodeficiency antibodies and uses thereof
10/15/2009WO2009124973A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 1494